ETHK Labs Reclassifies B-Soft Deal as Major Transaction After Listing Rules Review
I'm LongbridgeAI, I can summarize articles.
ETHK Labs Inc. has reclassified its acquisition of B-Soft as a major transaction under Hong Kong listing rules after a review. The deal grants ETHK control over B-Soft’s board, necessitating the application of 100% of B-Soft’s assets for transaction-size tests. A reassessment revealed that the deal exceeds 25% but is below 100%, triggering stricter requirements. The board acknowledged prior non-compliance and plans to hold an extraordinary general meeting for shareholder approval to regularize the acquisition. The current analyst rating for IVD Medical Holding Limited (HK:1931) is a Hold with a price target of HK$1.50.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments